TauTona Group

General contacts
Investor type

PE / VC

Founded

2010

AUM

-

Location

Redwood City, California, United States

Investment Ticket

$1-5 m

Investment Stage

Series A Seed Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 13 August, 2026

Profile

TauTona Group is a vertically-integrated operational fund based in Redwood City, California. Founded in 2010 by two professors from Stanford School of Medicine, it focuses on bioengineering, tissue regeneration, and stem cell therapies. The firm consists of a world-class team of doctors, researchers, engineers, and entrepreneurs who have contributed to the development of several medical devices, setting it apart with a contrarian and innovative approach to medical investments.

TauTona Group invests in medtech, biotech, and regenerative medicine, addressing unmet needs in healthcare with a sustainable investment model. The firm's current focus areas include minimally invasive surgeries, wound care management, and regenerative medicine. Its investment approach favors modest funding for developing technologies into commercial products, bypassing traditional venture capital layers.

Some of TauTona Group's notable innovations include the Pneumoperitoneum Assist Device (TPAD), BioBolt Surgical Stapler, and TauTona Wound Dressing (TWD). Previous acquisitions by major companies such as Allergan, LifeCell, and Novadaq highlight its capability to develop valuable healthcare solutions.

Industry

HealthTech MedTech Medical Devices Healthcare Services Biotechnology

Contacts

Name
Title
Email
Social Networks
avatar
Geoffrey C. Gurtner, MD Co-Founder & Managing Partner
Co-Founder & Managing Partner
g•••@•••
LinkedIn
avatar
Michael Longaker, MD Co-Founder and General Partner
Co-Founder and General Partner
m•••@•••
Upgrade to see contacts
avatar
VnpYqLmNka1WiGrw VnpYqLmNka1WiGrw
VnpYqLmNka1WiGrw
[email protected]
linkedin twitter
avatar
VnpYqLmNka1WiGrw VnpYqLmNka1WiGrw
VnpYqLmNka1WiGrw
[email protected]
linkedin twitter
avatar
VnpYqLmNka1WiGrw VnpYqLmNka1WiGrw
VnpYqLmNka1WiGrw
[email protected]
linkedin twitter
Investment-team contacts for TauTona Group — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about TauTona Group

TauTona Group is a venture capital and private equity firm. It backs companies at Series A, Seed, Series B and Late Stage (Series C+), writing tickets of $1-5 m.
TauTona Group is located in Redwood City, California, United States.
TauTona Group was founded in 2010.
TauTona Group invests in companies and startups in HealthTech, MedTech, Medical Devices, Healthcare Services, Biotechnology.
TauTona Group invests in companies and startups in North America.
TauTona Group invests in companies and startups at Series A, Seed, Series B, Late Stage (Series C+).
TauTona Group usually invests $1-5 m on average.
TauTona Group can be reached through its website tautonagroup.com, its LinkedIn page and its X account. Its general enquiries address is [email protected] . Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for TauTona Group — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query TauTona Group directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 13 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.